Porphysomes are a class of liposome-like nanoparticles that have demonstrated efficacy in photothermal therapy (PTT) and photodynamic therapy (PDT) against cancer. These nanoparticles results from the self-assembly of amphiphilic phospholipid-porphyrin (PL-Por) conjugates. Despite their potential, porphysomes exhibit a high photothermal effect and a weak photodynamic activity as long as they remain intact within the body. In this study, we present the design of a novel generation of smart porphysomes capable of undergoing active dissociation and releasing porphyrin moieties upon illumination, thereby enabling tunable photothermal properties with enhanced photodynamic efficiency. These new porphysomes are composed of smart PL-Por conjugates that exhibit one or two ROS-responsive linkers separating the polar head group from the porphyrin moiety. Among the designed molecules, we demonstrated that monosubstituted conjugates bearing either Pyro-a or Pheo-a porphyrinoids with one ROS-responsive bond and shorter linker showed the best performance in terms of stability, photothermal and photodynamic efficiencies in vitro. Moreover, these assemblies were found to achieve complete tumor ablation in 80 % of PC3 prostate subcutaneous tumor-bearing mice after 30 days post-PDT, compared to 0 % using conventional porphysomes. Consequently, our strategy enabled the development of a versatile platform for delivering porphyrin-based photosensitizers for enhanced photodynamic applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconrel.2025.113621 | DOI Listing |
ACS Appl Bio Mater
March 2025
College of Chemistry and Chemical Engineering, Qingdao University, Qingdao 266071, China.
Photodynamic therapy (PDT) has been demonstrated to be an effective tool for cancer treatment. Seeking organelle-targeting photosensitizers (PSs) with robust reactive oxygen species (ROS) production is extremely in demand. Herein, we propose an aggregation-induced photosensitization strategy for effective PDT with osmium complexes.
View Article and Find Full Text PDFJ Control Release
March 2025
Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Bâtiment Henri Moissan, 17, Avenue des Sciences, 91400 Orsay, France. Electronic address:
Porphysomes are a class of liposome-like nanoparticles that have demonstrated efficacy in photothermal therapy (PTT) and photodynamic therapy (PDT) against cancer. These nanoparticles results from the self-assembly of amphiphilic phospholipid-porphyrin (PL-Por) conjugates. Despite their potential, porphysomes exhibit a high photothermal effect and a weak photodynamic activity as long as they remain intact within the body.
View Article and Find Full Text PDFJ Inorg Biochem
March 2025
Key Laboratory of Functional Inorganic Material Chemistry, Ministry of Education, School of Chemistry and Materials Science Heilongjiang University, 74 Xuefu Road, Harbin 150080, China. Electronic address:
Singlet oxygen (O) is the main active ingredient in photodynamic therapy (PDT). However, an excess O can cause unnecessary toxicity. Therefore, it is of great importance to develop reliable and sensitive methods or probes for detecting O in biological systems.
View Article and Find Full Text PDFJ Tissue Viability
February 2025
Laboratory of Environmental Biophotonics, São Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil; Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.
Aim: This study aimed to evaluate the safety and efficacy of combined photodynamic therapy (PDT) and photobiomodulation (PBM) in treating sickle cell leg ulcers (SCLUs), with a focus on pain reduction and enhanced healing.
Materials And Methods: In this prospective, open-label, uncontrolled pilot study, ten SCD patients with 17 chronic leg ulcers received PDT and PBM treatments. Ulcer severity, pain levels, and microbiome changes were monitored, and clinical data were analyzed using appropriate statistical methods.
ChemMedChem
March 2025
Donghua University, Pharmaceutical Science & Technology, CHINA.
A novel pheophorbide derivative, trimethyl-152-[L-aspartyl]pheophorbide a was synthesised and investigated for anti-tumor activity. The prepared photosensitizer had good absorption in the phototherapeutic window and high ROS yields. It exhibited excellent phototoxicity higher than reference compound m-THPC when irradiated by 650 nm light in vitro, and obvious photodynamic anti-tumor effect in vivo.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!